{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:11:03Z","timestamp":1789963863185,"version":"4.0.1"},"reference-count":38,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:p>Selective estrogen receptor modulators (SERMs) have been developed as a means of targeting estrogen\u2019s protective effect on the skeleton in the treatment of postmenopausal osteoporosis. Although it is well established that SERMs such as tamoxifen inhibit bone resorption in a similar manner to estrogen, whether this agent shares estrogen\u2019s stimulatory action on bone formation is currently unclear. To address this question, we compared the effect of treatment for 28 d with 17\u03b2-estradiol (E2; 0.1, 1.0 mg\/kg\u00b7d) and tamoxifen (0.1, 1.0, or 10 mg\/kg\u00b7d) on cancellous bone formation at the proximal tibial metaphysis of intact female mice. E2 stimulated the formation of new cancellous bone throughout the metaphysis. A similar response was observed after administration of tamoxifen, the magnitude of which was approximately 50% of that seen after E2. As expected, E2 was found to suppress longitudinal bone growth, but in contrast, this parameter was stimulated by tamoxifen. We conclude that tamoxifen acts as an agonist with respect to estrogen\u2019s stimulatory action on bone formation but as an antagonist in terms of estrogen\u2019s inhibition of longitudinal growth, suggesting that the protective effect of SERMs on the skeleton is partly mediated by stimulation of osteoblast activity.<\/jats:p>","DOI":"10.1210\/en.2004-1114","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T01:29:19Z","timestamp":1102037359000},"page":"1060-1065","source":"Crossref","is-referenced-by-count":41,"title":["Tamoxifen Stimulates Cancellous Bone Formation in Long Bones of Female Mice"],"prefix":"10.1210","volume":"146","author":[{"given":"M. J.","family":"Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gujra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Whitworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Tobias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071612445712700_R1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S8756-3282(98)00156-2","article-title":"Does estrogen stimulate osteoblast function in postmenopausal women?","volume":"24","author":"Tobias","year":"1999","journal-title":"Bone"},{"key":"2020071612445712700_R2","first-page":"289","article-title":"Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study.","volume":"86","author":"Khastgir","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612445712700_R3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2003.18.5.925","article-title":"A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner\u2019s syndrome.","volume":"18","author":"Khastgir","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2020071612445712700_R4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"2020071612445712700_R5","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"2020071612445712700_R6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2020071612445712700_R7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071612445712700_R8","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071612445712700_R9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/jcem.83.4.4688","article-title":"Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.","volume":"83","author":"Marttunen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612445712700_R10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/endo.136.6.7750465","article-title":"Droloxifene, a new estrogen antagonist\/agonist, prevents bone loss in ovariectomized rats.","volume":"136","author":"Ke","year":"1995","journal-title":"Endocrinology"},{"key":"2020071612445712700_R11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/endo-122-3-1146","article-title":"Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficients rats.","volume":"122","author":"Turner","year":"1988","journal-title":"Endocrinology"},{"key":"2020071612445712700_R12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/endo.134.5.8156931","article-title":"The effects of raloxifene on tibia histomorphometry in ovariectomized rats.","volume":"134","author":"Evans","year":"1994","journal-title":"Endocrinology"},{"key":"2020071612445712700_R13","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1210\/endo.138.5.5109","article-title":"Clomiphene prevents cancellous bone loss from the tibia of ovariectomized rats.","volume":"138","author":"Jimenez","year":"1997","journal-title":"Endocrinology"},{"key":"2020071612445712700_R14","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1210\/endo.139.12.6343","article-title":"Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.","volume":"139","author":"Nuttall","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612445712700_R15","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1210\/en.2002-0074","article-title":"Estrogen receptor-\u03b1 dependency of estrogen\u2019s stimulatory action on cancellous bone formation in male mice.","volume":"144","author":"McDougall","year":"2003","journal-title":"Endocrinology"},{"key":"2020071612445712700_R16","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/j.1460-2075.1990.tb07469.x","article-title":"Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.","volume":"9","author":"Berry","year":"1990","journal-title":"EMBO J"},{"key":"2020071612445712700_R17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/(SICI)1097-4644(19990615)73:4<500::AID-JCB8>3.0.CO;2-E","article-title":"Comparative effects of estrogen and antiestrogens on differentiation of osteoblasts in mouse bone marrow culture.","volume":"73","author":"Qu","year":"1999","journal-title":"J Cell Biochem"},{"key":"2020071612445712700_R18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S8756-3282(01)00685-8","article-title":"The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro.","volume":"30","author":"Taranta","year":"2002","journal-title":"Bone"},{"key":"2020071612445712700_R19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/JBMR.0301249","article-title":"Transcriptional regulation of a BMP-6 reporter by estrogen receptor \u03b1.","volume":"19","author":"Ong","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2020071612445712700_R20","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.273.5279.1222","article-title":"Identification of an estrogen response element activated by metabolites of 17\u03b2-estradiol and raloxifene.","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"2020071612445712700_R21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/mend.14.5.0463","article-title":"Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.","volume":"14","author":"Wijngaard","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2020071612445712700_R22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0303-7207(01)00594-9","article-title":"Regulation of human cbfa1 gene transcriptio ni nosteoblasts by selective estrogen receptor modulators (SERMs).","volume":"183","author":"Tou","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612445712700_R23","first-page":"678","article-title":"Skeletal changes in mice receiving estrogen.","volume":"36","author":"Gardner","year":"1937","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071612445712700_R24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2106\/00004623-195032010-00014","article-title":"Endosteal bone formation in estrogen-treated mice","volume":"32A","author":"Urist","year":"1950","journal-title":"J Bone Joint Surg"},{"key":"2020071612445712700_R25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.1999.14.2.178","article-title":"High-dose estrogen induces de novo medullary bone formation in female mice.","volume":"14","author":"Samuels","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612445712700_R26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jnci\/85.10.806","article-title":"Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.","volume":"85","author":"Wolf","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"2020071612445712700_R27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S8756-3282(00)00289-1","article-title":"Is high-dose estrogen-induced osteogenesis in the mouse mediated by an estrogen receptor?","volume":"27","author":"Samuels","year":"2000","journal-title":"Bone"},{"key":"2020071612445712700_R28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2007-978618","article-title":"Tamoxifen prevents bone loss in castrated male mice.","volume":"32","author":"Broulik","year":"2000","journal-title":"Horm Metab Res"},{"key":"2020071612445712700_R29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1210\/en.2002-221108","article-title":"Raloxifene acts as an estrogen agonist on the rabbit growth plate.","volume":"144","author":"Nilsson","year":"2003","journal-title":"Endocrinology"},{"key":"2020071612445712700_R30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator function: a key to understanding tissue specificity of selective receptor modulators.","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr Rev"},{"key":"2020071612445712700_R31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/endo.142.3.8003","article-title":"4-Hydroxytamoxifen trans-represses nuclear factor-\u03baB activity in human osteoblastic U2-OS cells through estrogen receptor (ER)\u03b1, and not through ER\u03b2.","volume":"142","author":"Quaedackers","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612445712700_R32","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1210\/endo.139.9.6172","article-title":"Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.","volume":"139","author":"Sibonga","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612445712700_R33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/BF03343617","article-title":"The effects of SERMs on the skeleton.","volume":"22","author":"Tobias","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"2020071612445712700_R34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF03351042","article-title":"Response of biochemical markers of bone turnover to estrogen treatment in post-menopausal women: evidence against an early anabolic effect on bone formation.","volume":"24","author":"Fiore","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"2020071612445712700_R35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s001980050194","article-title":"Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy.","volume":"28","author":"Vedi","year":"1999","journal-title":"Osteoporosis Int"},{"key":"2020071612445712700_R36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"key":"2020071612445712700_R37","first-page":"E1159","article-title":"The effects of high-dose estrogen on murine hematopoietic marrow precede those on osteogenesis","volume":"279","author":"Perry","year":"2000","journal-title":"Am J Physiol"},{"key":"2020071612445712700_R38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/rp.57.1.385","article-title":"Sex steroids and bone.","volume":"57","author":"Manolagas","year":"2002","journal-title":"Recent Prog Horm Res"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/3\/1060\/9024571\/endo1060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/3\/1060\/9024571\/endo1060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T21:46:08Z","timestamp":1594935968000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/146\/3\/1060\/2500135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2004-1114","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}